Renal lithium clearance is hypothesized to be a useful indicator of renal tubular function. In this study lithium clearance will be monitored in patients with sepsis associated acute kidney injury and in healthy controls.
Lithium is almost completely reabsorbed in the proximal tubule in parallel with sodium and water. What is not reabsorbed here is assumed to be fully excreted in urine, giving a reasonably accurate measurement of sodium reabsorption in the proximal tubule. Endogenous lithium clearance will be measured by inductively coupled plasma mass spectrometry (ICP-MS). The Gomez equations will be applied to calculate efferent arteriolar resistance, afferent arteriolar resistance, glomerular hydrostatic pressure, glomerular filtration pressure, and glomerular oncotic pressure. N-acetyl-β-D glucosaminidase (NAG) and NGAL, markers of tubular injury, will be measured by a spectrophotometric method using a commercially available kit. Routine blood and urine analyses will be performed at the Diagnostic Clinic Laboratory, University Hospital of North Norway, Tromsø.
Study Type
OBSERVATIONAL
Enrollment
21
Measurements of lithium levels in blood and urine
University Hospital of North Norway
Tromsø, Troms, Norway
Renal lithium clearance
Measurement of renal lithium clearance at 8AM, 2 PM, and 8 PM
Time frame: Repeated measures between 07:00-20:00
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.